can you take contrave with semaglutide vs. Wegovy for Weight Loss: Some Differences to Know About The Real Facts About Contrave,

Medical disclaimer : This article is intended for educational and informational purposes only

A study published in August 2024 found a higher risk of NAION among patients prescribed semaglutide compared to individuals using non-GLP-1 receptor agonist medications, with 17 cases occurring in the semaglutide group versus six in the comparison group

(April 1990)

Ideal candidates for weight loss injections are generally healthy adults with realistic expectations of treatment and looking to lose excess weight

Its critical for brands, retailers, and foodservice providers to consistently monitor changing purchasing behaviors and health-driven trade-offs as consumers adopt, lapse, and return to these medications. The GLP-1 Trends Hub includes: Current state of GLP-1 adoption A demographic and geographic explorer Retail and aisle-level exposure Longitudinal purchasing impact data